Correlation Between Terns Pharmaceuticals and Spero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Spero Therapeutics, you can compare the effects of market volatilities on Terns Pharmaceuticals and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Spero Therapeutics.
Diversification Opportunities for Terns Pharmaceuticals and Spero Therapeutics
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Terns and Spero is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Spero Therapeutics go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and Spero Therapeutics
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to under-perform the Spero Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Terns Pharmaceuticals is 1.0 times less risky than Spero Therapeutics. The stock trades about -0.18 of its potential returns per unit of risk. The Spero Therapeutics is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest 126.00 in Spero Therapeutics on August 25, 2024 and sell it today you would lose (10.00) from holding Spero Therapeutics or give up 7.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Terns Pharmaceuticals vs. Spero Therapeutics
Performance |
| Timeline |
| Terns Pharmaceuticals |
| Spero Therapeutics |
Terns Pharmaceuticals and Spero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Terns Pharmaceuticals and Spero Therapeutics
The main advantage of trading using opposite Terns Pharmaceuticals and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.| Terns Pharmaceuticals vs. Lyra Therapeutics | Terns Pharmaceuticals vs. Hookipa Pharma | Terns Pharmaceuticals vs. SAB Biotherapeutics | Terns Pharmaceuticals vs. Cadrenal Therapeutics, Common |
| Spero Therapeutics vs. Lyra Therapeutics | Spero Therapeutics vs. Hookipa Pharma | Spero Therapeutics vs. SAB Biotherapeutics | Spero Therapeutics vs. Cadrenal Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |